Prof. Peter James

• 
  www.swegene.org/SWEGENE_kontakt_eng.html - [Cached Version]
  Published on: 8/5/2008    Last Visited: 8/5/2008  

  Professor Peter James Protein Technology, Wallenberg Laboratory II

• 
  www.laboratorytalk.com/news/agi/agi186.html - [Cached Version]
  Published on: 2/1/2002    Last Visited: 10/24/2002  

  Professor Peter James, director of proteomics at Swegene.Housed at the Dorint Maison Messmer in Baden-Baden and the Balmoral Hotel in Edinburgh, the Life Science Forums will give life scientist delegates the chance to meet researchers and decision makers, and catch-up with key players in this rapidly growing field.

• 
  www.bioinformatica.crs4.org/Members/eventman/seminars/p - [Cached Version]
  Published on: 6/12/2007    Last Visited: 6/3/2008  

  Fredrik Levander is working on method and software development for high-throughput proteomics in the group of Peter James, Lund

• 
  Active Communications International, Inc. - [Cached Version]
  Published on: 4/11/2002    Last Visited: 11/7/2006  

  Dr. Peter JamesProfessor of Protein Technology, Director of SWEGENE Proteomics

• 
  Amersham plc: Science Advisory Board - [Cached Version]
  Published on: 2/16/2004    Last Visited: 2/16/2004  

  Professor Peter JamesProf. of Protein TechnologyLund University

• 
  Business Briefings - Directory Listing - [Cached Version]
  Published on: 6/22/2003    Last Visited: 2/21/2004  

  Professor Peter James Professor of Proteomics, University of Lund

• 
  Contact - [Cached Version]
  Published on: 4/8/2006    Last Visited: 3/29/2008  

  Prof. Peter James

• 
  Editorials - [Cached Version]
  Published on: 3/14/2002    Last Visited: 2/25/2003  

  Peter James from Lund University described the use of separation of peptides (cleaved by non-specific proteases) by single or multidimensional HPLC to study membrane protein expression.Ruedi Aebersold from Institute for Systems Biology stressed the need to develop newer statistical models to study and validate the huge amount data generated by "omic " studies.

• 
  HUM-MOLGEN events: Genomics & Proteomics - [Cached Version]
  Published on: 11/29/2001    Last Visited: 2/17/2002  

  Peter James, Professor of Protein Technology, LUND INSTITUTE OF TECHNOLOGY.

• 
  HUPO 4th: HUPO 2005: Gynecologic & Obstetric - Ovarian... - [Cached Version]
  Published on: 10/14/2004    Last Visited: 2/23/2006  

  In this study, human ovarian cancer samples, classified by pathologists into one of four groups: normal, benign, borderline and malignant, were provided by Prof. Peter James, University of Lund, Sweden.The samples were analyzed by 2DDIGE and run in duplicates, using reciprocal labeling and sample randomization.

Page:  1 2